Executive Vice President,
Chief Technology Officer at Haemonetics
Partner, Bold Capital
Neal brings more than 30 years of investment and startup experience as General Partner of Bold Capital. Previously, Neal was co-founder and General Partner of Monitor Ventures (an early-stage venture fund) and head of commercialization for Interval Research, Paul Allen’s Silicon Valley incubator. Early in his career, Neal worked at the Boston Consulting Group. Neal’s original academic training was in Electrical Engineering from IIT Delhi, followed by an M.B.A. from Harvard Business School. Later he obtained a Ph.D. in Electrical Engineering from Stanford University.
Executive Vice President, Chief Technology Officer at Haemonetics
Said joined Haemonetics in 2018 as EVP, Chief Technology Officer. He leads the company’s innovation agenda and oversees research, development and medical and clinical affairs. He is responsible for developing technical capabilities and optimizing product and technology investments to drive accelerated growth.
Said has more than 20 years’ experience in health care and medical devices. Most recently, he was President, Ultrasound, at Siemens Healthcare, where he delivered positive growth and market share gains by rebuilding the product portfolio, improving sales and distribution capabilities and optimizing go-to-market strategies globally. He previously served as Vice President and General Manager of Intensive Insulin Delivery, Vice President of R&D and Chief Technology Officer for Medtronic’s Diabetes division, leading P&L as well as technology and product development. From 2004 to 2014, he held positions of increasing responsibility at General Electric’s Ultrasound division, including Global P&L Management, General Manager, Growth and Strategy; and Chief Technology Officer.
Said holds a B.S. in Electronic and Electrical Engineering from Cardiff University, University of Wales and a doctorate in Electrical Engineering from University of London, King’s College London. He holds numerous patents and publications.
Investment Director, Intel Capital
Eric is the Investment Director of Intel Capital's Connected Healthcare and IoT Communications Sectors. Eric oversees all of Intel Capital's equity investments in support of the company's Digital Health, Healthcare IT, and Medical Device focus areas. He initially joined Intel Capital in 2000. Eric has made investments in and currently serves on the Board of Medical Informatics Corporation and Aerial Technologies. In addition, he invested and managed successful exits for Sychip (acquired by Murata), Techfaith (IPO), and Ovonyx (acquired by Micron). Prior to Intel Capital, he spent several years in senior strategic business development roles for Intel's Internet of Things Group (IOTG), Communications and Devices Group (iCDG), and Client Computing Group (CCG).
Prior to Intel he served as the VP of Sales and Business Development as well as the CFO of venture-backed companies. Eric has an M.B.A. from Brigham Young University and has served as the Mayor of Folsom, California.
Janusz Bryzek, Ph.D.
Exo’s Co-Founder and Executive Board Chairman, Janusz is a pioneer in the fields of micro-mechanical integrated systems (MEMS) and sensors. He has co-founded 11 Silicon Valley MEMS companies with products including MEMS sensors (pressure, acceleration, gyro), MEMS microstructures (mirrors), sensor-based systems-on-chip (wireless pressure sensors, motion sensors with embedded sensor fusion) and systems (optical switches, medical ultrasound imagers). Janusz has performed due diligence for top-tier VC firms, including USVP (Irwin Federman), Mayfield, Benchmark, Morgenthaler, and Panorama. He also worked as an advisor or board member for 40+ startups.
Janusz has been the recipient of multiple awards, including “Entrepreneur of the Year” by Arthur Young in 1989, and Lifetime Achievement Awards in 1994 and 2003 by Sensors Magazine and MANCEF, respectively. In 2016, he was named Outstanding Polish Business Executive by the Polish Embassy in the United States and subsequently received the Industry Impact Award for Engineering Excellence from Sensors Expo in 2018.
He has published 250+ papers, wrote sections of four books, and has organized and chaired many international conferences. He is the author of 30 U.S. patents and multiple patent applications and has initiated several sensor standardization efforts.
Exo’s Co-Founder and Chief Executive Officer, Sandeep is a proven entrepreneur with a hands-on managerial background in leading interdisciplinary technology and business teams, and a track record of bringing to market complex hardware and software products. Exo is his fourth startup organization.
Prior to founding Exo, Sandeep was Founder and President of Jyve Inc. (acquired by a major semiconductor corporation at an exit valuation of more than $60M). Previously, he was CEO of IntelliSense, a leading provider of micro-mechanical integrated circuits (MEMS) and nanotechnology-based software and solutions. Under his guidance, IntelliSense expanded its physical presence into China and India and its sales presence into 30+ countries. Sandeep helped the company rapidly grow from a startup to its eventual acquisition at a valuation of $750 million. In 2003, he led the re-acquisition of IntelliSense from Corning.
Sandeep holds a B.Tech from the Indian Institute of Technology, an M.S. from LSU and an M.B.A. from INSEAD, France.